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Abstract
Filamentous bacteriophages have been used in numerous applications for the display of antibodies and random
peptide libraries. Here we describe the introduction of a 13 amino acid sequence LASIFEAQKIEWR (designated BT,
which is biotinylated in vivo by E. coli) into the N termini of four of the five structural proteins of the filamentous
bacteriophage fd (Proteins 3, 7, 8 and 9). The in vivo and in vitro biotinylation of the various phages were
compared. The production of multifunctional phages and their application as affinity reagents are demonstrated.
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Background
Biotinylation of proteins, nucleic acids, lipids and sugars
is without a doubt one of the most fundamental tools of
modern cell biology and biotechnology. This is due to
the scarcity of naturally biotinylated proteins (< 5 per
organism) [1-3], the chemical flexibility by which biotin
can be covalently conjugated to specific moieties of bio-
polymers and organic ligands, and the exceptional high
affinity binding between avidin/streptavidin and biotin
(KD =1 0
-14M) [4]. Hence, biotinylation provides the
means for extremely efficient affinity labeling and purifi-
cation of macromolecules, effective monitoring or track-
ing sub-cellular events, as well as the production of a
wide range of diagnostics, to mention only a few of the
areas where the Avidin/Biotin Complex ("ABC”)i sn o w
employed routinely [5,6].
Biotin (vitamin H) naturally exists as an obligatory co-
factor of carboxylase enzymes and functions as a car-
boxyl-carrier. These enzymes are ubiquitous, existing in
all organisms ranging from microbes to mammals [1-3].
In E. coli biotin carboxyl carrier protein (BCCP) is the
only protein that is biotinylated and is one of four subu-
nits of the enzyme acetyl CoA carboxylase which is
functional in fatty acid biosynthesis. BCCP is biotiny-
lated on the epsilon amine of lysine 122 via an amide
bond formed at the expense of ATP [7,8], a reaction
that is catalyzed by the biotin holoenzyme synthetase
(BHS the product of the BirA gene) [9]. The intact
BCCP is 156 amino acids long (16.7 kDa) however, the
actual cues for biotinylation are contained within only
the last carboxy terminal 66-75 amino acid residues of
the protein. Thus it has been illustrated that fusion pro-
teins expressing the biotinylation sequence are efficiently
biotinylated in vivo by E. coli or in vitro reaction-mix-
tures containing BHS [10-12]. Attempts to dramatically
trim the size of the peptide while maintaining its capa-
city for biotinylation in vivo have failed leading to the
conclusion that the enzyme requires a distinct confor-
mation around its Lys 122 (AMKM) and also depends
on additional contacts provided by other residues con-
tained within the minimal sequence of 30 amino acids
before and after the critical Lysine. Nonetheless, Schatz
[13] has demonstrated that a 13-15aa peptidomimetic of
the lysine-containing turn can be produced that is effi-
ciently recognized by BHS and can easily be used as a
biotinylation tag (BT) either N’ terminal or C’ terminal
to recombinant fusion proteins expressed in E. coli
(available now as a commercial biotinylation tag coined
“Avi-Tag”, GeneCopoeia, Inc., Rockville).
In this study we report the successful expression of
the BT at the N’ t e r m i n io ff o u ro ft h ef i v es t r u c t u r a l
proteins of the fd filamentous bacteriophage (Proteins 3,
7, 8, and 9). Each protein can be biotinylated in vivo
generating site-specifically biotinylated infectious fila-
mentous phage. The biotinylation of phages and their
potential applications are discussed.
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Construction of BT fused phage proteins
All phages were produced using the fth1 vector [14]
which were grown, harvested and analyzed by dot blot
and ELISA using standard protocols as previously
described in Tarnovitsky et al. [15]. Oligonucleotides
corresponding to the BT were introduced at the N’
terminal aspects of Proteins 3, 8, 7 and 9 as follows:
Protein 3
The modified fth1 vector shown in Figure 1 contains
two asymmetric BstX1 sites immediately following the
GCT alanine first codon of the N-terminus of mature
Protein 3. The following oligonucleotides coding for the
BT flanked with compatible overhangs -
p3BT-sense 5’-CTGGCTAGCGTCTATCTTCGAGG
CCCAAAAGATCGAGTGGCGACCAGACGT-3’
p3BT-antisense 5’-CTGGTCGCCACTCGATCTTTTG
GGCCTCGAAGATAGACGCTAGCCAGAGCT-3’
were cloned into BstX1 digested vector. DH5alpha
cells were transformed and BT containing clones were
isolated and confirmed for the correct sequence as well
as for BT expression as described in the text.
Protein 8
Phages containing BT fused to Protein 8 were generated
using two different approaches. The following oligonu-
cleotides coding for BT flanked with compatible Sfi1
overhangs were used in both systems
p8BT-sense 5’-ATCGCTAGCCTCTATCTTCGAGGC
CCAAAAGATCGAGTGGCGATCTG-3’
p8BT antisense 5’-ATCGCCACTCGATCTTTTGGG
CCTCGAAGATAGAGGCTAGCGATCGT-3’
Direct cloning of the BT into fth1 was performed
using fth1 restrict digested with Sfi1 and transformation
of DH5alpha cells. Alternatively, the gene for recombi-
nant Protein 8 derived from fth1 and containing the Sfi1
cloning cassette was cloned into pUC18 expression vec-
tor (GeneScript USA Inc., Piscataway NJ). This vector
was digested with Sfi1 into which the BT insert was sub-
sequently cloned. Similarly this modified pUC18 vector
was used to generate a recombinant Protein 8 expres-
sing the mAb CG10 binding peptide: CAKEGDLN-
KYKPWC [16]. In both cases DH5alpha cells were
transformed with the pUC18 expression vectors and
infected with various phages. This led to the production
of phages that could assemblem u l t i p l eP r o t e i n8u n i t s
displaying a variety of different peptides.
Proteins 7 and 9
The construction of BT containing Protein 7 and Pro-
tein 9 was performed using “gene SOEing” Overlapping
PCR as previously described in the construction of the
fth1 vector [14]. It is noteworthy that the termination
codon of Protein 7 overlaps with the initiation codon of
Protein 9 in an alternative reading frame. Hence the
integrity of both must be maintained during the con-
struction of the fusion proteins. Oligonucleotides corre-
sponding to the BT described above were introduced
into the 5’ aspect of the Protein 7 and Protein 9 genes
immediately after the first ATG codon.
Biotinylation in vivo and in vitro
The biotinylation of the recombinant phage proteins +
BT occurs in E. coli via endogenous BHS. However,
addition of 100 μM d-biotin (Sigma B-4501) to the
growth medium enhances the level of biotinylation.
Further substantial improvement can be achieved by
transforming the bacteria with the pBirAcm plasmid
(GeneCopoeia, Inc., Rockville) which contains the BirA
gene under the control of the tac promoter. This plas-
mid also contains the lac-i gene. As a result the expres-
sion of recombinant Protein 8 of the fth1 system is
markedly repressed in pBirAcm transformed cells as it
too is driven by tac promoter. The repression can be
overcome to some degree by isopropyl b-D-1-thiogalac-
topyranoside (IPTG) induction. However, marked
improvement is observed if the lac-i gene is simply inac-
tivated (see Figure 2). Inactivation of the lac-i gene was
accomplished by cleavage of the pBirAcm plasmid with
Apa1 which produces 3’ overhangs. These were polished
to generate blunt ends using DNA Polymerase 1 large
fragment (Klenow). Such treated vectors were then self-
ligated which leads to a truncated inactive lac-i gene
product.
Figure 1 Modification of fth1 vector for expression of peptides
at the N-terminus of Protein 3. The fth1 vector containing a
second recombinant protein 8 gene was further modified at the
native protein 3 gene. Two asymmetric BstX1 restriction sites were
introduced between the codons of Ala1 and Glu2 of Protein 3. The
BT was subsequently cloned into the BstX1 cloning cassette.
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turer’s protocol using the commercial Biotin Protein
Ligase (EC 6.3.4.15, GeneCopoeia, Inc., Rockville).
Solid phase immunoassays
Generally, ELISA and dot blots were performed as pre-
viously described [15]. Briefly, biotinylated bovine
serum albumin (Sigma, A8549) was plated into wells of
96 well plates in Tris buffered saline (TBS, pH7.5),
washed, quenched with TBS/milk solution and incu-
bated with streptavidin (10 μg/ml in TBS) and washed.
The wells were then incubated with the various phages
as indicated in the text and figures, washed and
reacted with rabbit anti-M13 followed by goat anti rab-
bit-IgG horseradish peroxidase conjugate. The wells
were developed with 3,3’,5,5’-tetramethylbenzidine sub-
strate solution and read at 650 nm in a BioTek plate
reader. Dot blots were prepared using nitrocellulose
membrane filters (BA 85 Whatman) and a 96 well
vacuum manifold (Whatman). Filters were quenched
with TBS/milk and reacted with antibodies as indicated
in the text and developed for enhanced chemilumines-
cence (ECL).
Affinity depletion and purification of antibodies from
polyclonal serum
Streptavidin magnetic beads (20 μl in 0.5 ml solution)
w e r ei n c u b a t e da nh o u ra tr o o mt e m p e r a t u r ew i t h1 0
10
phages expressing the HIV-1 gp41 pentameric loop epi-
tope (603-CSGKLIC-609) on Protein 8 and the BT on
Protein 7, or not. Serum from an HIV infected indivi-
dual (patient #I9809 [17]) was incubated with the beads
for one hour at room temperature. The bound antibo-
dies were eluted from the magnetic beads after TBS
washes and acidification with elution buffer (glycine-
HCl pH 2.2+1% BSA) as previously described [17]. The
void non-bound antibodies were collected as well. The
different fractions were analyzed by dot blot. For com-
parison phages expressing a second epitope
(CWGGTNWGQTPIVC, [17]) were also used.
Results
Filamentous bacteriophages have been used extensively
as expression systems for the production of combinator-
ial phage-display peptide [18,19] and antibody libraries
[20,21]. Although all five structural proteins have been
demonstrated as compatible for expression of fusion
proteins [22], two phage proteins have been found to be
particularly efficient.
Construction of site biotinylated phage proteins
Protein 3
Protein 3 is a multi-domain protein of 406aa present in
3-5 copies at the distal tip of the phage [23]. It is easily
compatible with the expression of foreign peptides as
large as a few hundred amino acids long and as such is
typically used in the production of antibody libraries
[20,21]. Foreign DNA inserts can be introduced into a
number of sites in this protein. As is shown in Figure 1,
using over-lapping PCR we have modified the fth1
expression vector and introduced a 30 bp insert contain-
ing a pair of BstX1sites between positions 1 and 2 of the
native protein. In such an instance all the Protein 3’so f
the phage are genetically modified. In order to first con-
firm that this new cloning site is compatible with func-
tional expression, the amino acid sequence AGFAIL
which corresponds to the epitope of the murine mono-
clonal antibody GV4H3 [24] was introduced into the
modified p3 gene. The specifically modified phages
acquire specific recognition by the GV4H3 mAb as
expected (not shown). Replacing the GV4H3 epitope
with the 13 amino acid biotinylation tag (BT = LASI-
FEAQKIEWR, [13]) generated a phage that incorporated
biotin that was confirmed by streptavidin binding (Fig-
ure 3).
Protein 8
Protein 8 encapsidates the entire length of the viral
ssDNA. Some 2700 copies of Protein 8 form a helical
Figure 2 The effect of lac-i inactivation. The peptide recognized
by the mAb CG10 was expressed on Protein 8 of fth1 phage.
Protein 3 of the same phage contained the BT. As is illustrated in
the dot-blot above, mAb CG10 binds 2X serial dilutions of the
phages (column 2) as opposed to the total lack of binding of the
control phage fth1 (column 1). Expression of the phages in
DH5alpha cells transformed with pBIRAcm dramatically reduces the
expression of the CG10 epitope (column 3). Addition of IPTG to the
cells induces the expression of the recombinant Protein 8 (column
4). Inactivation of the lac-i gene by digestion with Apa1 and self-
ligation dramatically improves the expression of the recombinant
Protein 8 without the need of IPTG (column 5). Reaction of a
duplicate filter with anti-M13 shows that the concentration of
phages for the 5 samples is the same. The in vivo biotinylation of
Protein 3 was measured by ELISA and samples 3-5 gave equal
signals (1.8-2.0 OD) as the promoter of Protein 3 is not repressed by
lac-i (not shown).
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tein is 50 residues long of which the greater part forms
an alpha helix that can close-pack against neighboring
Protein 8’s, where the carboxy termini interact electrosta-
tically via a cluster of four lysine residues with the DNA
while the N termini are free and amenable to molecular
manipulation [25]. Genetic alteration of the phages’ sin-
gle p8 gene leads to a phage that becomes homogenously
modified along its entire shaft where all 2700 copies con-
tain the foreign insert. It turns out, however, that inserts
exceeding 6-8 residues in length interfere with the pack-
ing of the Protein 8 into the growing filament of the
phage [18,26]. Expression of longer Protein 8 fusions is
possible however. This can be achieved when two p8
genes are functional; one expressing the wild type Protein
8 and the other the recombinant Protein 8 containing the
foreign peptide - ultimately leading to the production of
a “mosaic phage” where most of its Protein 8 is wild type,
interspersed with copies of recombinant Protein 8 [27].
The fth1 vector developed in our lab is a “type 88” [14]
vector which downstream to the natural wild type p8
gene, contains a second recombinant p8 gene modified
by the introduction of a pair of SfiI cloning sites in place
o ft h en a t i v eA s pr e s i d u e4o ft h en a t u r a lp r o t e i n .T h i s
vector has been used extensively to produce phage dis-
play peptide libraries that express inserts ranging from 3-
50 residues long.
For the incorporation of BT into Protein 8 we adopted
two approaches. As is shown in Figure 3 a DNA insert
corresponding to the BT can be introduced directly into
the SfiI cloning sites rendering the production of Protein
8 biotinylated phages.
An alternative approach for expression of multiple types
of Protein 8 in a single phage is also possible. For this we
constructed a pUC18 plasmid for the expression of an
independent recombinant Protein 8 in a bacterium
infected with the fth1-phage. As is shown in Figure 4, we
have performed secondary modification of three distinct
phages: (i) fth1 phage that expresses only wild type Protein
8 (as no insert is introduced in the second recombinant p8
gene of fth1), (ii) a “4H3” phage where the AGFAIL pep-
tide corresponding to the GV4H3 mAb described above
has been cloned into the SfiI sites of the second p8 gene of
the fth1vector, and finally (iii) the “CG10” phage that
expresses via the SfiI cloning sites a peptidomimetic of the
Figure 3 Biotinylation in vivo and in vitro of phage proteins 3,
7, 8 and 9. The BT was introduced into the phage proteins 3, 7, 8
and 9 and compared with fth1 phage as indicated. The phages
were tested by quantitative ELISA for the presence of biotin with
(stipple and black) or without (grey and hatched) lac-i modified
pBIRAcm for in vivo biotinylation (grey and stipple) compared with
subsequent in vitro biotinylation (hatched and black).
Figure 4 Production and biotinylation of multi-functional
phages. Phages were produced either without any insert (fth1), or
containing epitopes for mAbs 4H3 or CG10, both antibodies
directed against HIV gp120. The three phages were then used to
infect E. coli bacteria that had been transformed with either pUC18
expressing a Protein 8 fusion with the CG10 epitope or with BT as
indicated. Three identical dot-blots of the phages generated from
these transformed cells were probed with mAbs 4H3, CG10 or with
Streptavidin-HRP (SA). All the phages derived from the BT-
transformed bacteria express biotinylated Protein 8 as well as the
other corresponding markers, thus illustrating the possibility for
multi-functionality of the phages.
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[16]. Each of these phages was then used to infect E. coli
that had previously been transformed with the pUC18
plasmids containing a Protein 8 fusion in which either the
BT or the CG10 peptidomimetic are expressed. As is seen,
all three phage-types become detectable with HRP conju-
gated streptavidin when they are grown in pUC18-BT
transformed bacteria. This system illustrates that one can
easily introduce into a single phage a diversity of Protein 8
recombinants. It also proves the possibility of simple bioti-
nylation of pre-existing phages expressing desired peptides
or antibodies by simply culturing them in the pUC18-BT
transformed bacteria.
Proteins 7 and 9
There has been little documented experience in modifica-
tion of Proteins 6, 7 and 9. Protein 6 packs with Protein 3
at the distal tip of the phage and has been used for car-
boxy-terminal expression [28]. At the other end of the
phage, Proteins 7 and 9 are involved in recognition of the
DNA packaging signal of the phage (a short 78 base hair-
pin in the ssDNA [29]) and are thought to initiate the
extrusion of the phage particles thus forming the proximal
tip of the mature phage. The compatibility of Protein 7 or
Protein 9 with the expression of foreign peptides as
fusions has been somewhat unclear. Endemann et. al.i n i t i -
ally reported that only Protein 9 was accessible to the sur-
face of the phage yet could not be used for expression
[30]. Since then Gao et. al. illustrated that both Protein 7
and Protein 9 tolerate N-terminal manipulation (as
opposed to lack of compatibility of the C termini of both
proteins) yet in order to obtain expression it appeared that
a phagemid system was required ensuring that at least
some wild type Protein 7 and Protein 9 were co-expressed
in the phages [31]. Maintaining these conditions, Gao
expressed VL domains of a number of antibodies in Pro-
tein 7 while simultaneously expressing the cognate VH of
each mAb on Protein 9 thus realizing functional specific
antigen recognition illustrating that both phage proteins
could be employed for functional N-terminal fusions. As is
depicted in Figure 3 we constructed modified Protein 7
and Protein 9 as N-terminal fusions of BT. In both cases
we were able to detect streptavidin binding to recombi-
nant phages. This indicates, therefore, that both proteins
are compatible with fusion protein expression without the
need of a phagemid-derived second wild type protein.
Modification of Protein 7 and Protein 9 in this case does,
however, reduce the total amount of phages produced
resulting in titers markedly lower than would otherwise be
expected. One might question however, whether or not
the modified Protein 7 or Protein 9 interfere with the
function of these proteins in infectivity. Therefore, we
tested the ability of the modified phages to infect DH5al-
pha cells. In these experiments it was found that bacteria
incubated with phages containing recombinant Protein 7
or Protein 9 could infect the cells as indicated by acquisi-
tion of resistance to tetracycline as well as continue to
produce recombinant progeny illustrating that the modi-
fied proteins are able to participate in the extrusion of
functional phages.
In vivo vs. in vitro phage biotinylation
The four phage protein constructs described above illus-
trate that the BT can be incorporated functionally into
the proteins and produce biotin-containing phages
which are extruded into the media. The question is
whether the majority of BT’s are actually biotinylated in
vivo or rather are expressed but missed by the cytoplas-
mic enzymatic machinery? Should the latter be the case,
one could expect an increase of biotinylation per phage
in subsequent in vitro biotinylation reactions. Hence the
following experiments were conducted.
First, the effect of adding biotin to the culture medium
w a st e s t e da n df o u n dt h a ta d d i t i o no f1 0 0μMo fb i o t i n
improved the level of in vivo biotinylation (not shown).
However, the most dramatic improvement was seen when
bacteria were co-transformed with a plasmid containing
the BirA gene (see Figure 3). Thus five different phages
were compared for biotinylation: phages containing N-
terminal BT for Proteins 3, 8, 7 and 9 respectively com-
pared to the fth1 phage as a negative control. The level of
biotinylation, as monitored by quantitative ELISA using
Streptavidin-HRP as the probe, was measured for biotiny-
lation in vivo in the presence or absence of the BirA plas-
mid. The harvested phages were then subjected to in vitro
biotinylation. As can be seen for Proteins 3 and 8 in vivo
biotinylation was markedly enhanced in the bacteria co-
transformed with the BirA containing plasmid. The subse-
quent in vitro reactions did not however, improve the level
of biotinylation substantially. This most probably indicates
that for these two proteins the N-terminal BT is accessible
in the cytoplasm of the bacterium. Thus increasing the
level of BirA improves the efficiency of biotinylation and
for the most part the majority of BT’s become pre-tagged
before the phage is extruded. This does not seem to be the
case for Proteins 7 and 9. Here in vitro biotinylation
improves the level of biotin incorporation. Curious how-
ever is the observation that elevating cellular BirA tends to
reduce the availability of sites for subsequent in vitro bioti-
nylation. This could indicate that biotin-tagging of these
cellular proteins interferes to some degree with their
membrane transport, assembly or phage extrusion.
Affinity depletion and purification of antibodies using
biotinylated phages
Affinity depletion of dominating antibodies from polyclonal
serum
HIV-1 infected individuals tend to mount a strong anti-
body response towards the gp41 pentameric loop
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n a ls e r u mt y p i c a l l yg e n e r a t e sn u m e r o u sp h a g e st h a t
represent this dominating epitope often to the extent
that other activities are overshadowed. Hence it
becomes desirable to reduce the dominance of the anti-
pentameric loop response by selective depletion of those
antibodies specific for this epitope. For this, a phage dis-
playing the pentameric loop on Protein 8 and biotiny-
lated on Protein 7 was used as an affinity reagent.
Polyclonal serum was applied to the biotinylated phages
bound to streptavidin-magnetic beads. As is illustrated
in Figure 5 the serum that flows through the beads is
markedly depleted of antibodies specific for the penta-
meric loop. The specific antibody can then be eluted off
the column. As expected affinity depletion or purifica-
tion is not achieved using phages that express the penta-
meric loop but are not biotinylated.
Discussion
Here we have reported the site specific biotinylation of
four of the five structural proteins of the fd filamentous
bacteriophage. Biotinylation of bacteriophages has been
reported in the past by others. The majority of these
studies have involved the chemical modification of
mature infectious phages by standard means such as the
use of the N-hydroxy succinimide ester of biotin [32,33].
Whereas this is an efficient way to incorporate biotin
onto phages, such chemical procedures do not afford
the specificity or the control to attach the biotin to one
antigen or other or restrict the modification to a dis-
crete lysine residue. Moreover, the chemical biotinyla-
tion could incorporate biotin to critical lysines or other
selected residues and lead to interference with phage
function (note for example that the pentameric loop of
gp41 contains a lysine residue). In vivo biotinylation of
phage capsid proteins has been demonstrated for phages
such as lambda whose assembly is cytoplasmic and does
not require membrane transport of biotinylated proteins
as is the case for filamentous phages (see below).
Ansuini et. al. exploit this fact in an elegant report in
which the BT serves as a tag for functional open reading
frame expression of cDNA libraries [34].
The biosynthetic pathway for filamentous phage extru-
sion is exceptionally interesting as it is complicated
[23,35,36]. Briefly, the phage genome encodes for 9
open reading frames plus two over-lapping reading
frames giving 11 proteins. Of these, five are structural
proteins comprising the proximal tip of the phage (Pro-
teins 7 and 9), the shaft of the phage (Protein 8) and the
distal tip (Proteins 3 and 6). At the initiation of assem-
bly the phage structural proteins are all present as inte-
gral membrane proteins of the inner membrane with
their N termini facing the periplasmic space. At first,
the ssDNA to be packaged is encapsidated in cytoplas-
mic Protein 5 which has a distinct binding preference
for single strand DNA [29]. Thus a short double
stranded hairpin of the phage-DNA is devoid of Protein
5 and serves as a packaging signal recognized by the
periplasmic membrane associated proteins, Proteins 9
and 7. Binding of these to the packaging signal initiates
phage assembly. Now membrane associated Protein 8
moves laterally in towards the site of assembly sequen-
tially replacing tiers of the Protein 5 subunits thus build-
ing the new capsid of the phage stepwise and extending
outward into the medium [37]. When the DNA is fully
encapsidated with Protein 8 subunits, Proteins 6 and 3
j o i nt h ee n s e m b l ea n de f f e c t i v e l ya l l o wt h ef u l l y
extended phage to snip off into the medium without
causing the bacterium to lyse [38]. The fact that all four
of the proteins studied in this report can be detectably
biotinylated would suggest that either biotinylation
occurs in the periplasm or that cytoplasmically biotiny-
lated protein can be translocated through the inner
membrane.
Biotin holoenzyme synthetase (BHS), the BirA gene-
product, is in fact a cytoplasmic enzyme [1,9]. Moreover,
it has been demonstrated that cytoplasmically biotiny-
lated proteins such as alkaline phosphatase or maltose
binding protein can be transported into the periplasmic
Ɍ 5mer 
1 2 3 4 5 
Ɍ 12mer 
Ɍ fth1 
Figure 5 Selective affinity depletion of serum using
biotinylated phages. Phages “12mer” and “5mer” express two
epitopes of HIV (12mer: CWGGTNWGDTPIVC, 5mer: CSGKLIC). The
total activity of HIV+ polyclonal serum is shown in strip #1. The
serum was applied to 5mer-phages biotinylated on Protein 7 and
bound to streptavidin magnetic beads. Strip #2 illustrates the affinity
purified antibodies specific for the 5mer eluted off the column. Strip
#3 shows the depleted serum after passing over the 5mer column.
As a control the columns were prepared using the same 5mer
phages but not biotinylated at all. Strip #4 shows that in this
situation practically no antibody can be eluted off the column and
all the activity passes through the column as is shown in strip #5.
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biotin per se does not necessarily interfere with mem-
brane transport in E. coli. Transport of proteins in E.
coli is mediated by a number of different and distinct
systems (e.g., SRP, Sec, and YidC transport systems
[41,42]). Manipulating the transport system can have a
profound effect on the efficacy of biotinylation where
slowing the transport down tends to increase the yield
of in vivo biotinylation of proteins destined to be trans-
ported into the periplasmic space [39,40]. Steiner et. al.
illustrated that replacing the Sec translocation signals
for co-translational SRP translocation signals improved
dramatically the display of proteins on phage protein 3
[43].
Regardless the translocation system, all four phage
proteins described here were found to be biotinylated in
vivo and assembled into functional phages. However,
cytoplasmic tagging of Proteins 7 and 9 did seem to
impair the yield of phage production.
The existence of the biotinylated phage components
m a yb eu s e f u lf o rt h es t u d yo fp h a g eb i o s y n t h e s i sa n d
assembly and should afford opportunities in following
the pathway of the proteins from ribosomal translation
to membrane transport and assembly. One may also be
able to exploit these constructs to follow the fate of the
protein components of incoming infectious phages into
the host bacterium.
The ability to efficiently biotinylate phages with preci-
sion should open new avenues for the biotechnological
application of phages. In vivo biotinylation of phage Pro-
tein 3 has already been reported. Scholle et. al., for
example, devised a unique system whereby a short ran-
dom peptide library expressed on Protein 3 is followed
by an AviTag sequence. The biotinylated phages are
then captured on immobilized Streptavidin and reacted
with proteases. Those phages that are released display
peptides that are cleavable by the enzyme being investi-
gated [44]. As shown here peptide specific phages can
be produced carrying endogenous biotin moieties with-
out the concern of effecting the properties of the affinity
ligand and shown to enable antibody depletion or affi-
nity purification. Certainly the same could be done
using phages that express antibodies or receptor-specific
ligands and thus generate easily obtained capture
reagents for purification protocols. More intriguing
could be the unique situation whereby the use of tar-
geted in vivo biotinylation we can selectively tag one tip
or other of the phage or phages with multiple functional
moieties. Thus one can envision the oriented immobili-
zation of phages to solid supports. Directional and
orientated immobilization of phages could produce dis-
tinct optical signatures as opposed to random immobili-
zation. This and other attributes of targeted
biotinylation could afford new applications for phages
where precise and regulated manipulation may be
required.
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